Abstract
Introduction
reticulum function [2, 3] , altered transcripts for Ca regulatory proteins [4] [5] [6] , a more controversial change in In an attempt to elucidate the intracellular mechanisms the corresponding proteins [7] , altered protein phosphorylassociated with contractile dysfunction in congestive heart ation [8, 9] and changes in ion channels [10, 11] in the failure, a number of laboratories have investigated the failing human heart. processes of excitation-contraction coupling in failing and
In spite of the number of studies which have been 21 non-failing human hearts. Studies have demonstrated aldevoted to Ca cycling in heart failure, only recently has 21 tered levels of intracellular Ca [1] impaired sarcoplasmic attention focused on the annexins, a novel family of 21 Ca -binding proteins which are abundant in the heart and may play an important role in cardiac excitation-contrac- 21 tion coupling. Ca -binding proteins, such as calmodulin, 4658. E-mail address: moravec@ccf.org (C.S. Moravec) 1 Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Regulatory Biology at Cleveland State University.
Time for primary review 26 days. [14] [15] [16] [17] [18] [19] . Annexin IV has been found to inhibit the Ca LS5lisinopril; ML5milrinone; MT5metroprolol; *medications taken by activity of the cardiac Na / Ca exchanger [18] . In the the patient prior to transplant.
heart, studies have suggested the presence of these three annexins, as well as annexin II and possibly annexins III and VIII [25] [26] [27] [28] [29] .
Materials and methods
The importance of annexins in the cardiovascular system has not been established. All members of the family are 2.1. Tissue source anti-coagulants [12] . Preliminary studies have suggested a role for the annexins in ischemia-reperfusion injury, Twelve explanted human hearts were obtained from where they may regulate phospholipid homeostasis [27] or patients undergoing cardiac transplantation at the Cleve- 21 mediate increased Ca influx [30] . Annexins III, IV and V land Clinic Foundation. Six non-failing human hearts were have been shown to increase in the plasma of patients obtained from unmatched organ donors, as previously following myocardial infarction, presumably being redescribed [32] . Of the patients with heart failure, five had a leased from injured heart cells [31] or possibly from diagnosis of end stage ischemic heart disease (ICM), and vascular endothelial cells [12] . Gunteski-Hamblin and seven had a diagnosis of idiopathic dilated cardiomyopathy colleagues have recently shown that overexpression of (DCM). Characteristics of individual patients are summaannexin VI in the heart results in decreased intracellular rized in Tables 1 and 2 . All hearts were arrested with cold 21 cardioplegic solution in the operating room (composition in Ca cycling and impaired contractility [19] , suggesting a mmol / l: NaCl 147.2, MgCl 16.0, KCl 20.0, NaHCO role for at least one of the cardiac annexins in excitation-2 3 10.0 and CaCl 2.25) and were immersed in the same contraction coupling. 2 solution for transport to the laboratory. Time between In pathophysiological states, the relative amount of explant of the heart and arrival in the laboratory did not annexins found in the heart may be altered. Work by Song exceed 30 min for failing hearts and 90 min for non-failing and co-workers, examining annexin levels in the explanted hearts (due to time in transit from the donor institution). hearts of cardiac transplant recipients, has demonstrated a significant increase in the expression of annexin V and a Table 2 decrease in the expression of annexin VI [29] . These data Once in the laboratory, tissue was immediately separated homogenizer at 48C. Protein concentration was determined by heart chamber, frozen in liquid nitrogen, and stored at according to the method of Bradford [33] with bovine 2808C until use. serum albumin as the standard. Homogenates were stored The lung, liver, kidney and skeletal muscle samples at 2808C until use. were specimens collected by the Department of Pathology Samples were solubilized in Laemmli sample buffer at the Cleveland Clinic Foundation at the time of routine (Bio-Rad Laboratories, Hercules, CA) for 5 min at 958C. surgical procedures. All protocols described in this manuEqual amounts of protein from each sample were subjected script were approved by the Institutional Review Board of to SDS-PAGE using the Laemmli buffer system [34] in a the Cleveland Clinic Foundation and the investigation Mini-Protean II Dual Slab Cell (Bio-Rad Laboratories). All conforms with the principles outlined in the Declaration of samples were run until complete elution of the dye front. Helsinki.
Proteins were transferred to nitrocellulose in a Mini Trans-Blot Transfer Cell (Bio-Rad Laboratories), accord-2.2. Immunocytochemistry ing to the procedure of Towbin [35] . The transfer was completed at 48C at a constant voltage setting of 100 V for Endocardial trabecular muscles were dissected from the 1 h. The blots were blocked in 5% gelatin diluted in left ventricle and right atrium of each heart. Muscles were Tris-buffered saline (TBS), composition: 20 mmol / l Trissecured on small pieces of wax and frozen in liquid HCl, pH 7.4, 150 mmol / l NaCl, for 1 h at room temperanitrogen. The frozen muscles were stored at 2808C until ture. The blots were washed three times for 5 min each and preparation for sectioning.
were incubated in the primary antibody solution diluted Frozen longitudinal sections (4 mm) were cut from the 1:500 in TBS, containing 0.1% gelatin, overnight at 48C. surface of each muscle, using a cryostat (Shandon A5620,
The same primary antibodies were used for both Western Analytical instruments, Plymouth, MN). These sections blots and immunolocalization (described above). The blots were used for all immunocytochemical reactions.
were washed three times for 15 min in TBS and were After fixation in acetone at 2208C for 20 min, the incubated in secondary antibody at a dilution of 1:10 000 sections were air dried, rinsed in phosphate buffered saline in the same buffer as above for 1 h at room temperature. (PBS), incubated at room temperature with blocking buffer
The blots were again washed three times for 15 min, and (PBS, containing 2% goat serum, 5% Triton X-100, 5% developed using the Vistra ECF Western blotting system glycine) for 1 h and then incubated with the primary (Amersham, Chicago, IL). Proteins were quantified using antibody, 1:25 mouse anti-annexin IV clone 4 (Transducthe Molecular Dynamics Storm Imager and ImageQuant tion Laboratories, Lexington, KY), 1:25 goat anti-annexin PC software (Molecular Dynamics, Sunnyvale, CA). For V R-20 (Santa Cruz Biotechnology, Santa Cruz, CA), and each band, normalization was performed by the value of a 1:150 mouse anti-annexin VI clone 73 (Transduction non-failing heart used as a standard on all blots. The Laboratories, Lexington, KY), diluted in PBS containing secondary antibodies used for Western blots were: anti-2% goat serum, 0.5% Triton X-100 and 5% glycine, at mouse IgG alkaline phosphatase conjugated (Vistra sysroom temperature for 1 h (annexin VI) or overnight at 48C tems) and rabbit F(ab9)2 anti-goat IgG alkaline phospha-(annexin IV and V). After rinsing with PBS, the secondary tase conjugated (Southern Biotechnology Associates, Birantibody, diluted 1:250 in the same buffer, was applied and mingham, AL). incubated at room temperature for 1 h in the dark. Human lung, liver, kidney, skeletal muscle and heart left As a positive control for the specificity of the primary ventricle and right atrium, devoid of fibrotic or adipose antibodies used in this study, we performed Western blot tissue, were homogenized in a threefold volume of glyanalysis using a variety of human tissues samples. and lung (LN). Anti-annexin IV antibody recognized a experiments the characteristic plasma membrane staining major band at approximately 34 kD identified as annexin for annexin VI was not evident when the tissues are IV, and a minor band of approximately 68 kD, which may incubated with anti-annexin IV antibody, demonstrating no represent a cross reaction with the annexin VI protein.
important cross-reactivity in these studies. Anti-annexin V antibody recognized a specific band of Fig. 3 shows a representative Western blot and bar graph approximately 32.5 kD in all tissues. The other bands of annexin IV protein levels in the left ventricle and right observed in the blot are due to non-specific binding of the atrium from non-failing, ICM and DCM hearts. There was secondary antibody and were also present when the blot a statistically significant increase in the amount of annexin was incubated with secondary antibody alone (data not IV protein in both ICM and DCM hearts as compared to shown). Anti-annexin VI antibody specifically recognized a non-failing hearts. In the right atrium, however, there were band at approximately 68 kD in all tissues studied. no differences in the amount of protein between either DCM and non-failing or ICM and non-failing hearts. 3.1. Annexin IV 3.2. Annexin V For the immunolocalization studies, one representative failing heart is compared to one representative non-failing Longitudinal sections from left ventricle and right heart. Among the failing hearts, there were no differences atrium stained with anti-annexin V antibody are shown in in the location of any of the annexins between DCM and Fig. 2E -H. In these sections, a clear cross-striated pattern ICM hearts. When the heart sections were stained for is observed in all tissues ( Fig. 2E-H ). In the failing annexin IV ( Fig. 2A-D) , a strong staining was observed ventricle (Fig. 2F) and atrium (Fig. 2H) , however, a more around the yellow lipofuscin granules (Fig. 2A, open disorganized cross-striated pattern is evident, with areas arrow). Additionally a punctate longitudinal staining was where annexin V is localized as green brilliant dots in the also evident as shown in the non-failing left ventricle (Fig. cytosol (brackets in Fig. 2F and H) . In addition, staining 2A, triangles). Also, the cross striation pattern observed in for annexin V accumulated around the lipofuscin granules the non-failing atrium (Fig. 2C) was absent in the failing and at the intercalated discs (arrowhead in Fig. 2E ). atrium (Fig. 2D) , which showed diminished intracellular Staining for annexin V in the cytosol of non-myocyte cells staining. In summary, a loss of annexin IV organization is also evident in the majority of the sections and is clearly was evident in both failing tissues, (Fig. 2B and D) when shown in Fig. 2G (bidirectional arrow). compared with the non-failing tissues ( Fig. 2A and C) . Fig. 4 shows representative Western blot analyses and Interestingly, although our Western blots showed a the corresponding bar graphs for annexin V in ventricle possible cross reaction of the anti-annexin IV antibody and atrium from failing and non-failing hearts. Results with the annexin VI protein, in these immunostaining show a significant increase in the protein levels of annexin On all blots, 17, 33 and 51 mg of total left ventricle (top) and right atrium (bottom) protein from the same non-failing heart (standard heart) was blotted. For normalization purposes, densitometric units obtained from each heart were divided by the average value of the standard heart from the same blot. Each value represents the mean of three independent determinations. *P,0.05 vs NF.
V in the left ventricle of ICM and DCM as compared to sponding bar graphs for annexin VI in total homogenate of non-failing. In the right atrium, there were no significant left ventricle and right atrium of failing and non-failing changes in the expression of annexin V between nonhuman hearts are shown in Fig. 5 . There were no signififailing and either group of failing hearts.
cant differences in the protein levels of annexin VI between non-failing and ICM or non-failing and DCM 3.3. Annexin VI hearts in either left ventricle or right atrium.
Annexin VI (Fig. 2I-L) was localized at the sarcolemma and intercalated disc in the ventricle and atrium from both 4. Discussion non-failing ( Fig. 2I and K) and failing ( Fig. 2J and L) human hearts. However, in the non-failing left ventricle
We chose to study left ventricular tissue because of the (Fig. 2) , a striation pattern was also observed in the large contribution of left ventricular performance to overall majority of the sections (closed arrow). This pattern was cardiac output and its impairment during heart failure. absent in the majority of failing left ventricle sections (Fig. Right atrium was studied in preference to left atrium 2J). The failing atrium (Fig. 2L ) also showed staining in a because the human right atrium is trabeculated, facilitating longitudinal pattern, but this pattern was not observed in the removal of muscle preparations comparable to those the non-failing atrium (Fig. 2K) .
found in the ventricle, and thus more easily compared. A representative Western blot analysis and the correIn this study, we have shown that (1) annexin IV, V and On all blots 17, 33 and 51 mg of total left ventricle (top) and right atrium (bottom) protein from the same non-failing heart (standard heart) was blotted. For normalization purposes, densitometric units obtained from each heart were divided by the average value of the standard heart from the same blot. Each value represents the mean of three independent determinations. *P,0.05 vs NF.
VI are localized in distinct cellular compartments within failure [38, 39] . Differential regulation of both the amount 21 the cardiomyocytes of the human heart and, in some cases, and the location of other proteins involved in Ca the characteristic intracellular location of these proteins is cycling, such as the annexins, has also recently been altered in the failing human heart; (2) annexin IV and V reported in human heart failure [29] . protein levels are up-regulated in the left ventricle but not
The fact that annexins IV, V and VI immunolocalize in in the right atrium of failing human hearts; and (3) annexin different compartments within cardiomyocytes may sug-VI is not significantly altered in the ventricle or atrium of gest a different role for each annexin in the heart. failing human hearts.
Moreover, the up-regulation of two of these proteins in the It has been established that human heart failure is left ventricle, the most dysfunctional chamber in the failing 21 characterized by contractile changes, which are accomheart, along with other reported abnormalities in Ca 21 panied by abnormalities in intracellular Ca cycling [36] cycling, supports the hypothesis that annexins may play a 21 and alterations in the steady state levels of both mRNA role in Ca handling in the human heart. 21 and proteins involved in Ca cycling, (see Ref. [37] for Annexin IV is one of the most abundant annexins review). Changes in the expression of E-F hand motif present in many cell types. Neither the function nor the 21 Ca binding proteins, such as calmodulin [24] have also location of the annexin IV protein has been investigated in been reported. Disorganization of sarcomeres and the the heart. However, in epithelial cells, annexin IV is cytoskeleton, as well as an abnormal arrangement of known to be a cytoplasmic marker of the polarization of contractile proteins, has been reported in human heart the cell, either at the basolateral domain [40] or at the On all blots 17, 33 and 51 mg of total left ventricle (top) and right atrium (bottom) protein from the same non-failing heart (standard heart) was blotted. For normalization purposes, densitometric units obtained from each heart were divided by the average value of the standard heart from the same blot. Each value represents the mean of three independent determinations. A value of P,0.05 was accepted as statistically significant.
apical domain [41] and it has also been shown to modulate ventricle [26] . The same striation pattern was observed 21 a Ca dependent chloride channel in these cells [14] . In later when Wang and colleagues examined double stained the human heart, our results show that annexin IV is rat cardiomyocytes with anti-annexin V and anti-a-actin by localized in the cytoplasm of cardiomyocytes and that in confocal laser scanning microscopy, suggesting that annexthe failing tissues there is a loss of intracellular organizain V localized in association with the z-line of rat cartion. Annexin IV protein levels are also significantly diomyocytes and was associated with the actin filaments increased in the ventricle of both DCM and ICM hearts. [28] . Similarly, in the human heart, our current results Annexin V and VI have been described as the major show that annexin V immunolocalizes with a cross-striated cardiac annexins [26] . Their exact function, as well as the pattern spaced at approximately 2 mm, suggesting a immunolocalization of annexin V, remain controversial. It localization at the z-line. In the failing heart, we show that has been shown in both rat [42] and guinea pig [43] hearts annexin V tends to cluster in the cytosol of cardiomyocytes that annexin V is localized on the intercalated discs and on with a lack of organization. These results are consistent the sarcolemma of cardiac isomyocytes. Spreca and colwith the findings of Hein and co-workers [39] whose leagues found annexin V localized at the sarcolemma, immunohistochemistry experiments show changes in both T-tubule system and intercalated discs [44] . Doubell and the amount and organization of titin, myosin and thin co-workers described an immunoreactivity at the sarcolemfilament complex in human hearts. ma of atrial muscle, and the intercalated disc of ventricular
The localization of annexin V at the z-line, and also the muscle, as well as a striated pattern in both atrium and up-regulation of annexin V protein in the left ventricle, are 21 consistent with a role for annexin V in altered Ca Acknowledgements handling in the human heart during failure. The up-regulation of annexin V in DCM and ICM human hearts agrees
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